Close Menu

Keith Robison has a humorous post on the increasing catchiness of the former nerds-only term "DNA." Any number of companies have started referring to things as being in their DNA, which leads Robison to wonder just what they mean by that. Are they suggesting, he asks, that they have a lot of redundancy, or that "a lot of pieces of the organization resemble decayed portions of other pieces of our organization"? Definitely check it out -- it'll make you laugh.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.